Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst3 receptor antagonists

被引：15

作者：

Troxler, Thomas ^{[1
]}

Hurth, Konstanze

Schuh, Karl-Heinrich

Schoeffter, Philippe ^{[1
]}

Langenegger, Daniel ^{[1
]}

Enz, Albert ^{[1
]}

Hoyer, Daniel ^{[1
]}

机构：

[1] Novartis Inst BioMed Res, Neurosci Dis Area, CH-4002 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 05期

关键词：

Somatostatin; GPCR; Somatostatin sst(3) receptor; Non-peptidic somatostatin receptor ligands; Subtype-selective sst(3) receptor antagonists; CSF SOMATOSTATIN; BRAIN; IDENTIFICATION; BINDING; GROWTH; SAR;

D O I：

10.1016/j.bmcl.2010.01.063

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Starting from non-peptidic sst(1)-selective somatostatin receptor antagonists, first compounds with mixed sst(1)/sst(3) affinity were identified by directed structural modifications. Systematic optimization of these initial leads afforded novel, enantiomerically pure, highly potent and sst(3)-subtype selective somatostatin antagonists based on a (4S,4aS,8aR)-decahydroisoquinoline-4-carboxylic acid core moiety. These compounds can efficiently be synthesized and show promising PK properties in rodents. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：1728 / 1734

页数：7

共 33 条

[1] Aourz N, 2009, EPILEPSIA, V50, P176
[2] The development of a practical synthesis of the potent and selective somatostatin sst3 receptor antagonist [4-(3,4-difluoro-phenyl)-piperazine-1-yl]-{(4S,4aS,8aR)-2[(S)-3(6-methoxy-pyridin-3-yl)-2-methyl-propyl]-decahydroisoquinoline-4-yl}-methanone (NVP-ACQ090)
Bänziger, M
Cercus, J
Hirt, H
Laumen, K
Malan, C
Spindler, F
Struber, F
Troxler, T
[J]. TETRAHEDRON-ASYMMETRY, 2003, 14 (22) : 3469 - 3477
[3] HYPOTHALAMIC POLYPEPTIDE THAT INHIBITS SECRETION OF IMMUNOREACTIVE PITUITARY GROWTH-HORMONE
BRAZEAU, P
VALE, W
BURGUS, R
LING, N
BUTCHER, M
RIVIER, J
GUILLEMIN, R
[J]. SCIENCE, 1973, 179 (4068) : 77 - 79
[4] Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation
Colucci, R.
Blandizzi, C.
Ghisu, N.
Florio, T.
Del Tacca, M.
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (02) : 198 - 209
[5] Dalm VASH, 2004, J NUCL MED, V45, P8
[6] Dobbelaar P. H., 2009, [No title captured], Patent No. [WO2009011836, 2009011836]
[7] DORAN AR, 1986, ARCH GEN PSYCHIAT, V43, P365
[8] Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors
Engin, Elif
Treit, Dallas
[J]. PSYCHOPHARMACOLOGY, 2009, 206 (02) : 281 - 289
[9] Somatostatin, Alzheimer's disease and cognition: An old story coming of age?
Epelbaum, Jacques
Guillou, Jean-Louis
Gastambide, Francois
Hoyer, Daniel
Duron, Emmanuelle
Viollet, Cecile
[J]. PROGRESS IN NEUROBIOLOGY, 2009, 89 (02) : 153 - 161
[10] Fendt M, 1996, J NEUROSCI, V16, P3097

← 1 2 3 4 →